CME — CME Group Inc.
Is CME overbought or oversold? Here is the current MarketMoodz read.
CME Group Inc. (CME) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Financial Services name (Financial Data & Stock Exchanges) last closed at $311.56. The rating moved from Neutral to Overbought on November 14, 2026.
- Public ratingOverbought (as of November 17, 2026)
- Last close$311.56
- Last changeMoved from Neutral to Overbought on November 14, 2026
- SectorFinancial Services
- IndustryFinancial Data & Stock Exchanges
See all overbought Financial Services stocks →
AI analysis
CME Group operates a durable, high-margin global derivatives and clearing franchise with diversified, recurring revenue streams and meaningful product optionality. Its market-leading liquidity, clearing relationships and data/technology offerings underpin steady cash generation and shareholder returns. Near-term volumes depend on macro volatility and trading activity, but product expansion (including digital-asset derivatives) and secular growth in institutional derivatives use provide upside. Key challenges include regulatory scrutiny, episodic volume swings tied to market volatility, and operational/clearing risk in stressed episodes.
Key factors
- CME Group Inc. (CME) is the dominant global listed derivatives marketplace with deep liquidity across interest-rate, equity, FX, agricultural and crypto futures — strong network effects and high client switching costs.
- Diversified revenue mix: trading & clearing fees, market data & index/licensing and technology services support recurring, high-margin cash flows and resilience through cycles.
- Structural demand for risk management and yield-seeking products benefits CME as institutional adoption of derivatives and listed cleared products grows.
- Product innovation and expansion (e.g., expanded options, micro-contracts, digital-asset derivatives) provide incremental revenue opportunities and broaden the client base.
- Strong free cash flow generation, a history of shareholder returns (dividend + buybacks), and conservative balance-sheet metrics support capital allocation flexibility.
- Clearinghouse franchise and collateral/initial margin mechanics create stickiness and a durable competitive moat vs. newer venues.
- Near-term market environment (measured risk-on, low volatility) may moderate volumes but does not materially impair CME’s structural positioning.
Risks
- Sustained low volatility and subdued macro-driven trading volumes would pressure fee-based revenue and weaken near-term topline growth.
- Heightened regulatory scrutiny of exchanges, clearinghouses and digital-asset products could lead to higher compliance costs, product restrictions or fines.
- Competition from electronic venues, OTC-to-exchange migration uncertainty, or crypto-native platforms could pressure market share in certain products.
- Clearinghouse credit and operational risk in stressed market events could create reputational and capital demands.
- Index-provider and institutional rebalancing dynamics (including crypto-treasury-linked flows) can introduce episodic volume swings and margin volatility.
- Technology incidents, cyber events or outages could cause trading disruptions and client trust erosion.
Latest MarketMoodz coverage
- 4% CD Yields Reappear — Practical Guide for Income Investors2026-06-30
- ICE, CME Among Most Oversold Stocks; Rebound Ahead?2026-06-27
- KBW: Buy the Dip in CME Group — Perpetual Fears Overblown2026-06-18
- CME to Sue CFTC Over Perpetual Futures, Duffy Says2026-06-17
- Terry Duffy to Step Down as CME CEO; Lynne Fitzpatrick to Succeed2026-06-17
See today's live rating, score and targets
Members see the live hourly rating for CME — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.